This review aims to evaluate the contribution of individual cell-selective knockout models to our current understanding of androgen action. Cre/loxP technology has allowed the generation of cell-selective knockout models targeting the androgen receptor (AR) in distinct putative target cells in a wide variety of organs and tissues including: testis, ovary, accessory sex tissues, muscle, bone, fat, liver, skin and myeloid tissue. In some androgen-regulated processes such as spermatogenesis and folliculogenesis this approach has lead to the identification of a key cellular mediator of androgen action (Sertoli and granulosa cells, respectively). In many target tissues, however, the final response to androgens appears to be more complex. Here, cell-selective knockout technology offers a platform upon which we can begin to unravel the more complex interplay and signaling pathways of androgens. A prototypic example is the analysis of mesenchymal-epithelial interactions in many accessory sex glands. Furthermore, for some actions of testosterone, in which part of the effect is mediated by the active metabolite 17b-estradiol, conditional knockout technology offers a novel strategy to study the relative contribution of AR and estrogen receptor-mediated signaling. The latter approach has already resulted in a better understanding of androgen action in brain and bone. Finally, cell-selective knockout technology has generated valuable models to search for AR-controlled molecular mediators of androgen action, a strategy that has successfully been applied to the study of androgen action in the testis and in the epididymis. Although some conditional knockout models have provided clear answers to physiologic questions, it should be noted that others have pointed to unexpected complexities or technical limitations confounding interpretation of the results.
Introduction
The androgen receptor (AR), a member of the nuclear receptor family, plays a central role in androgen signaling. Ligand binding to this receptor causes activation and interaction of the AR with androgen response elements (ARE), located in the regulatory regions of androgen-responsive genes. This binding subsequently results in the modulation of gene expression. Many effects of androgens, however, depend on more complex signaling pathways. For a comprehensive understanding of these complex actions at least three additional elements need to be taken into consideration. First, some effects of androgens depend on the production of ''active metabolites'' such as 5a-dihydrotestosterone (DHT) and 17b-estradiol (Wilson, 1975) . DHT, an AR ligand, is produced by 5a reduction of testosterone (T). Whereas aromatization of T results in 17b -estradiol which is a ligand for two other nuclear hormone receptor family members: the estrogen receptors ERa and ERb. Second, many effects of androgens are indirect (Verhoeven and Swinnen, 1999) . Indirect effects may be mediated by a variety of mechanisms, including: androgen-induced changes in the concentration of secondary transcription regulators, androgen-induced changes in the secretion of autocrine or paracrine regulators, or androgen-induced changes in the level of other endocrine hormones such as GH. Third, some effects of androgens require androgen action during a very discrete and often short time period (Welsh et al., 2008) . Androgen action during such a critical window induces changes that are often irreversible or only partially reversible. Absence of androgen action during this window results in defects that cannot be restored by androgen exposure at alternative time points. These additional elements play a very important role in complex androgen-regulated processes such as sexual differentiation.
Various approaches have been used to study the effects of androgens and its downstream signaling pathways. Nonetheless, in many target tissues androgen action remains incompletely understood. Surgical or pharmacological castration experiments have contributed substantially to our understanding of the major virilizing and anabolic effects of androgens. In some species, however, the testis is not the only source of androgens. Moreover, depending on the age at castration, gonadectomy does not reverse, or only partially reverses differentiating effects of androgens such as the ones involved in the development of the male phenotype or male sexual behavior. Finally, surgical castration obviously impedes the ability to study the effect of androgen action in one of the most important androgen target tissues: the testis. In addition to the disadvantages listed for castration experiments, the use of anti-androgens may have effects of their own (androgenic or others). Moreover, effects of androgen metabolites, such as estrogens will not be blocked. Finally, the study of animals with genetic defects in the AR that cause complete or partial androgen insensitivity has been very useful for the analysis of the effects of androgens on developmental processes. The female phenotype of these animals, however, complicates the interpretation of studies on the role of androgens in sexual behavior and the cryptorchid position of the testis in these models precludes studies on the role of the AR in the control of spermatogenesis.
The advent of recombinant DNA technology allowing cell-selective inactivation of the AR (for review: (De Gendt and Verhoeven, 2009) ) has created novel opportunities for the dissection of the cellular and molecular signaling pathways involved in the more complex effects of androgens. In this review we focus on the contribution of these conditional knockout models to our understanding of androgen action in male and female animals.
2. Cre/loxP technology: a tool for custom gene inactivation
General
All the presently reported models in which the AR has been inactivated in a cell-or tissue-selective way have been generated by means of Cre/loxP technology (Nagy, 2000) . This technology makes use of the site-specific recombinase Cre (cyclization recombination) from the bacteriophage P1 which is used to induce recombination between two 34 bp recognition sites (termed loxPsites, locus of crossing [X-ing] over in P1) inserted in the genome. LoxP sites contain two 13 bp inverted repeat sequences surrounding an 8-bp core sequence that gives them their directionality. Because of this directionality, loxP-sites are usually depicted in genomic sequences as arrowheads.
Two transgenic mouse strains are needed to generate a cellselective knockout: one strain in which the Cre recombinase is expressed under the control of a suitable cell-selective promoter, and a second strain in which the gene of interest -or a functionally critical exon thereof -is flanked by two loxP-sites ('floxed'). After one round of crossbreeding, double transgenic progeny carrying both the floxed transgene and the Cre transgene can be selected by genotyping. In a second round of breeding, these double heterozygous transgenic mice are either inbred or crossed again with the original floxed mouse line. In the resulting F2 generation, pups that are homozygous for the floxed allele and that carry the Cre transgene (in a homo-or heterozygous state) are selected. In the latter animals, the floxed gene/exon will be excised selectively in the cell types that express Cre recombinase. In the case of the AR gene (which resides on the X chromosome), this breeding scheme can be simplified when only male progeny is studied. Indeed, male mice that are hemizygous for the AR flox allele and that carry the Cre transgene can be obtained in the F1 generation by breeding Cre expressing males with AR flox/+ females. Thus, AR inactivation in the male can be achieved in only one round of breeding.
The creation of a floxed transgene suitable for cell-selective knockout experiments requires attention to two specific details. First, care should be taken that the introduction of the loxP sites does not affect the normal expression level or the expression pattern of the targeted gene. Such interference might in and of itself induce a phenotype in the floxed transgenic mice, confounding the interpretation of the phenotype of the final cell-selective knockout. For the same reason, antibiotic resistance cassettes used for selection during the gene targeting procedure should be removed either in vitro (in embryonic stem cells) or in vivo (through crossbreeding with mouse lines weakly expressing Cre in the germline). Second, loxP-sites inserted into the genome should be oriented in the same direction. This orientation will allow Cremediated excision of the floxed DNA fragment leaving only one residual loxP-site in the genome. LoxP sites oriented in an opposite direction result in Cre-mediated inversion of the floxed DNA segment, a reaction that is reversible since the two loxP-sites remain intact after the recombination event.
Mouse strains with a floxed AR allele
Five mouse strains carrying a floxed AR allele have thus far been generated and three different exons have been targeted (Table 1) . Interestingly, these different strains have resulted in different models that allow the study of various aspects of AR function and physiology. Residual mutant AR protein, hyperandrogenization (Notini et al., 2005) , (Kato, 2002) ; Ar flox(ex1-neo) , (Holdcraft and Braun, 2004) ) carry a floxed exon 1. The underlying idea is that elimination of exon 1 will not only delete the N-terminal domain of the AR that is important for transcriptional activation, but will also delete part of the proximal promoter and the transcriptional start site of the AR gene prohibiting expression. Ubiquitous AR knockout models have been generated using both mouse strains and male AR knockout mice show the expected complete androgen insensitivity phenotype, suggesting that AR activity is completely abolished after Cre-mediated excision. In one of these strains ), however, a neomycin selection cassette is left in intron 1. This results in decreased AR gene expression in the Ar flox(ex1-neo) strain and in a hypomorphic phenotype reflected in a general reduction in androgen sensitivity, reduced testis and seminal vesicle weight, impaired spermatogenesis, and increased serum gonadotrophin levels. Although this is itself an interesting model of partial androgen insensitivity, the hypomorphic phenotype confounds the interpretation of cellselective knockout models generated using this floxed mouse strain. Furthermore, the loxP-sites in the Ar flox(ex1-neo) strain are positioned in opposite directions, resulting in an inversion rather than an excision of the targeted exon 1. It is unclear whether and to what extent the reversibility of this inversion affects the phenotype of cell-selective knockout mice generated with this model. Two mouse strains have been generated targeting exon 2 of the AR (fAR, (Yeh et al., 2002) ; AR flox , (De Gendt et al., 2004) ). Deletion of AR exon 2 causes a frameshift in the AR open reading frame, leading to a premature termination codon and subsequent mRNA degradation. For both mouse strains Cre-mediated excision has been shown to result in undetectable AR protein levels. The AR flox line has been characterized extensively with respect to potential effects on reproductive function and no abnormalities have been observed (De Gendt et al., 2004; De Gendt et al., 2005; Tan et al., 2005) .
Finally, a mouse strain with a floxed AR exon 3 was reported by Notini et al. (2005) (AR lox ). Interestingly, elimination of exon 3 from the AR transcript does not cause a frameshift in the AR coding sequence and as a result a truncated AR protein is expressed, which lacks the second zinc finger of the DNA binding domain. This mutant AR is unable to bind AREs and to modulate the expression of androgen-regulated genes. Conditional knockout models making use of this mutated AR allele may be able to distinguish classical genomic effects of androgens (requiring a functional DNA-binding domain) from so-called non-genomic effects (supposedly mediated through other AR protein domains). Quite surprisingly, in this AR lox strain, the insertion of the loxP sites in the AR gene causes a mild hyperandrogenization phenotype with increased weight of androgen-dependent tissues such as kidney, seminal vesicle, levator ani muscle and heart. Testis weight, fertility and serum testosterone levels are not detectably affected. This observation reaffirms the need to investigate the potential phenotypic effects of floxed alleles in the absence of Cre in tissue-specific knockout studies (MacLean et al., 2008a) .
Mouse strains expressing Cre recombinase (Cre-lines)
Another important consideration is the choice of a suitable Creexpressing mouse strain. A thorough characterization and validation of the spatiotemperal pattern of Cre expression is key to a successful cell-selective knockout project (De Gendt and Verhoeven, 2009 ). Often, Cre-lines show spatiotemporal expression patterns that diverge from the ones predicted for the promoter driving Cre expression. Therefore, it is essential that new Cre-lines are validated for their specific applications by crossing them with so called ''reporter'' mice. These mice carry a reporter gene (LacZ, EGFP, alkaline phosphatase, etc.,) that is activated after Cre-mediated excision. These and other pitfalls such as mosaicism (variable expression of the Cre enzyme in the targeted cells) and differences in genetic background affecting the efficiency of Cremediated excision, have recently been reviewed focusing on models relevant for testicular physiology (Smith, 2011 ). An overview of Cre-expressing strains and their use in cell-selective AR ablation studies is presented in Table 2 .
3. Cell-selective knockouts of the AR and the study of fertility in the male
The study of androgen action in the testis is an excellent example of the power of cell-selective gene inactivation technology (Fig. 1) . In male animals the testis is not only the main source of androgens, it is also one of the most important androgen target organs. In fact, spermatogenesis has long been known to be highly dependent on the presence and action of androgens. Germ cells themselves, however, do not express AR (Bremner et al., 1994; Grootegoed et al., 1977) and do not need cell-autonomous expression of AR for normal development (Johnston et al., 2001) . A possible role for 'direct' androgen action on germ cell development and fertility was further ruled out by the generation of a germ cellselective AR knockout model (Tsai et al., 2006) . No reproductive phenotype was observed in these animals. Thus, androgen action is thought to be mediated 'indirectly' via the somatic cell types that sustain spermatogenesis. The relative contribution of each of these cell types (Sertoli cells (SC), Leydig cells (LC), peritubular myoid cells (PTMC)), however, remains only partially understood. SC are generally considered prime candidates for the mediation of androgen action because of their intimate anatomical and functional interactions with the developing germ cells but AR expression is also clearly evident in PTMC and in LC. Moreover, there are a lot of data suggesting that androgen-mediated interactions between SC and PTMC play an important role in the development and function of seminiferous tubules. Since this topic has been extensively reviewed recently (Matsumoto et al., 2008; Verhoeven et al., 2010 ; Walters et al., 2010; Wang et al., 2009; Zhou, 2010) , we will limit the present discussion to the most relevant data.
SC-selective AR knockouts
The role of AR expression in SC as it relates to spermatogenesis has been demonstrated unambiguously by the development of several SC-selective AR knockout models. A Cre recombinase driven by the anti-Müllerian hormone (AMH) promoter has proven to be extremely valuable for the development of these models.
Two models have been generated in which AR exon 2 was deleted in SC: SCARKO mice (De Gendt et al., 2004) and S-AR À/Y mice . Both models use the same AMH-Cre strain (official name: Tg(AMH-cre) 1Flor ; (Lecureuil et al., 2002) ). In both models, knockout mice display a normal external male phenotype, but testicular size is reduced due to a complete block in spermatogenesis at the level of meiosis. Whereas mice with a general knockout of the AR (ARKO, Tfm) are cryptorchid, SCARKO and S-AR À/Y mice display a normal testicular descent. Accordingly, the observed spermatogenic defect is due to the absence of androgen action and not to an abnormal positioning of the testis. The defect in germ cell development observed in SCARKO and S-AR À/Y animals is at least as severe as that observed in WT androgen depletion models suggesting that the majority of the spermatogenic effects of androgens are mediated by the classical, genomic AR-dependent signaling pathway. AR-dependent, non-genomic effects, however, cannot completely be excluded.
Recently a SC-selective knockout model has been generated using mice with a floxed AR exon 3 (Lim et al., 2009) . The model uses the same AMH-Cre line as in the exon 2 studies described above. These mice (SCAR
DZF2
) display a phenotype similar to that of SCARKO and S-AR À/Y mice and the authors conclude that nongenomic actions of androgens, which may occur through the previously described truncated AR that is expressed, play only a minor role in the regulation of spermatogenesis by SC. In the same study, the AMH-Cre line is compared with a newly generated mouse line expressing Cre under the control of the androgen-binding protein (ABP) promoter (ABP-Cre, official name: Tg(Abpa-cre) 1Cmal ). Cre expression in the latter line is shown to be restricted to SC, but to be less efficient, leaving a fraction of the SC with an intact AR.
One of the limitations of the above described SC-selective knockout models is that -given the block in meiosis -these models do not allow the study of potential effects of androgens on postmeiotic germ cell development. In this respect it is interesting to note that in testes of a mouse model with decreased AR expression (Ar flox(ex1-neo)/Y ) the remaining germ cells complete meiosis, but subsequently fail to complete spermiogenesis (Holdcraft and Braun, 2004) . This finding supports the contention derived from other experimental paradigms (McLachlan et al., 2002; Singh et al., 1995) that the phases of germ cell development demonstrate different sensitivities to androgen action. The completion of meiosis requires a lower threshold of androgen activity and thus is less sensitive to decreased AR levels in this model. In contrast, normal levels of AR and/or androgen action are needed for spermiogenesis to occur. SC-selective inversion of AR exon 1 in this model using a different AMH-Cre line (official name: Tg(Amh-cre) 8815Reb (Holdcraft and Braun, 2004) ) generates a mouse model (Ar flox(ex1-neo)/Y ; Amh-cre) in which spermatogenesis is even further suppressed. Nonetheless, the spermatogenic defect is less dramatic than that observed in other SC-selective AR knockout models, suggesting that AR ablation is incomplete. It is unclear to what extent the reversibility of the Cre inversion event may explain these discordant findings.
The discussed models also stress the importance of paracrine interactions between different cell types in the testis. In 2-dayold ARKO mice the number of SC is reduced by 50% whereas in SCARKO mice the number of SC is normal (O'Shaughnessy et al., 2002; Tan et al., 2005) . This suggests that the effect of androgens on SC number is not directly mediated by AR in SC but by another testicular target of androgen action, conceivably PTMC. All the described models indicate that AR ablation in SC affects Leydig cell function and development but the extent of this effect is variable.
S-AR
À/Y mice display marked hypotestosteronemia, whereas in SCARKO mice serum T levels are not significantly reduced, an observation that is in agreement with the normal serum LH levels and the unchanged weights of androgen-dependent accessory sex glands. Nonetheless, further study of Leydig cell development in SCARKO mice shows that, at an adult age, the number of LC is reduced by 40% and that the remaining LC show compensatory hypertrophy allowing them to keep serum T levels in the normal range. This suggests that the SC AR is needed for the production of a paracrine factor that controls Leydig cell development and function .
Comparison of the transcriptome in the testes of mice with a SC-selective AR knockout and control mice has highlighted different molecular pathways that may be particularly sensitive to androgen regulation (for review: (Verhoeven et al, 2008 ). Several genes involved in retinoic acid metabolism, protease/protease-inhibitor balance, and genes encoding cytoskeletal and junctional components have been shown to be differentially expressed (Denolet et al., 2006; Eacker et al., 2007; O'Shaughnessy et al., 2007) . This differential expression has been confirmed in functional studies were the SC barrier (SCB) was shown to be defective in SCARKO mice. Although earlier studies have claimed that the SC AR is essential for junctional complex formation or that the SCB is breached in the absence of the SC AR (Meng et al., 2005 ), a recent study shows that the disturbances are more subtle: a functional SCB is formed in SCARKO testes, but its formation is delayed and partially disturbed . Intriguingly, SCB formation seems to be enhanced in tubules where more developed germ cells are present, raising the question of the role of developing germ cells in this process.
LC-selective AR knockout
Earlier studies have demonstrated a role for androgens in LC development and function (Hardy et al., 1990) . Indeed, LH-stimulated androgen secretion in LC stimulates LC maturation and constitutes an autocrine positive feedback loop. Consequently, LCselective ablation of the AR can be expected to result in a complex phenotype, where any changes due to the LC-selective AR disruption have to be interpreted in the context of reduced androgen secretion. Xu et al., (2007) reported the expected reduction in T biosynthesis and secretion in their LC AR knockout mice (L-AR À/Y ) and showed that this reduction was caused by changes in the expression of several key steroidogenic enzymes, rather than by a reduction in LC number. The defect in androgen secretion -also reflected in elevated serum LH levels -likely accounts for the concomitant disruption of spermatogenesis at the round spermatid stage. However, that the AR knockout in this model may not be restricted to the LC only is still a consideration in interpreting these results. Indeed, the anti-Müllerian hormone receptor 2 (Amhr2) promoter used to drive the Cre was also shown to be expressed and to display variable, gene-dependent, activity in SC (Jeyasuria et al., 2004; Kyronlahti et al., 2011) . Accordingly, it is difficult to exclude that partial AR elimination in SC may contribute to the observed phenotype.
PTMC-selective AR knockouts
The somatic cells in the testis that display the earliest expression of the AR protein are the PTMC. Moreover, in these cells the level of AR expression remains high throughout life. In vitro studies using co-cultures of SC and PTMC or PTMC-conditioned media have indicated that, under the influence of androgens, PTMC secrete one or more paracrine factors, modulating the function of SC (P-Mod-S). P-Mod-S factors act as indirect stimulators of a number of SC functions, including the secretion of transferrin and inhibin and as inhibitors of FSH-induced aromatase activity (Skinner, 1991; Verhoeven et al., 2000) . Comparable stromal-epithelial interactions have been described in many other organs of the male reproductive system (e.g., in the prostate).
Conditional knockouts ablating the AR in PTMC have shed new light on these types of interactions. A first model targeting PTMC has been generated by Zhang et al. (2006) using a mouse strain in which Cre expression is controlled by the promoter of smooth muscle protein 22a (SM22 or transgelin). The resulting AR knockout model shows normal fertility associated with a slight reduction in testis weight and oligospermia. However, the Transgelin-Cre was later shown to be poorly active in PTMC and to be preferentially expressed in vascular smooth muscle cells in the testis (Frutkin et al., 2006) . A detailed study of this model (Welsh et al., 2010b) shows that AR activation in blood vessel smooth muscle cells is important for vasomotion and testicular fluid dynamics. Ablation of the AR in vascular smooth muscle cells is associated with compensated LC failure, suggesting that normal LC function and differentiation are at least partly dependent on androgen action in vascular smooth muscle cells.
In a recent study by Welsh et al. (2009) a new PTM-ARKO model has been generated using a smooth muscle myosin heavy chain (smMHC) promoter driven Cre line. Although the efficiency of the AR knockout in PTMC reaches only 40%, these mice display a distinctly more severe phenotype. The testis weight of adult PTM-ARKO mice is strongly decreased and the germ cell numbers are severely reduced, with almost no elongated spermatids. The reduction in postmeiotic germ cells in PTM-ARKO mice is at least partly mediated by effects of PTMC on SC. Indeed, the authors show that in this model the expression of several SC androgen-regulated genes is also disturbed, providing further evidence for a role of androgen-driven stromal-epithelial interactions in the control of spermatogenesis.
4. Cell-selective knockouts of AR and the study of fertility in the female AR is widely expressed in organs and tissues of female animals and the effects of excessive androgen action in the female are widely recognized. The role of androgens in female physiology, however, is less well understood and animals with generalized or targeted defects in AR expression may represent excellent tools to explore this important issue in more detail.
A role for AR in female reproduction was already suggested by experiments in the seventies with XO female mice carrying the Tfm mutation on the X chromosome (Ohno et al., 1973) and experiments with X Tfm /X Tfm females bred by making use of males chimeric for the Tfm allele (Lyon and Glenister, 1980) . These experiments indicated that, although AR is not absolutely essential for reproduction in the female, defective AR action leads to reduced reproductive performance and premature ovarian failure suggesting a role for androgens in follicular maturation and atresia. The use of Cre/LoxP technology considerably facilitates the generation of female mice with a global knockout of AR (ARKO) (Hu et al., 2004; Shiina et al., 2006; Walters et al., 2009; Yeh et al., 2002) and also creates the possibility to generate a variety of cell-selective knockouts. ARKO females are subfertile, produce fewer litters and fewer pups per litter. They also display ovulatory dysfunction and defects in follicular development. Accelerated follicle depletion is observed in some but not all ARKO models. The mechanisms behind these reproductive defects, however, remain to be elucidated. Intra-ovarian androgen target cells (oocytes, granulosa cells, theca cells) as well as extra-ovarian sites of androgen action (hypothalamus, hypophysis) may be involved (Walters et al., 2010) .
In an attempt to elucidate which AR-expressing target cells are responsible for the physiologic effects of androgens on female fertility and ovarian function, Sen and Hammes (2010) recently developed cell-selective knockouts targeting the AR in either granulosa cells or oocytes.
A Cre-recombinase knocked into the AMH receptor type II (AMHR2) locus (Jamin et al., 2002) was used to target the granulosa cells. AMHR2 is expressed in the coelomic and mesenchymal epithelium surrounding the Müllerian duct, the female urogenital ridges and granulosa cells (GC) of both embryonic and adult ovaries (Teixeira et al., 2001) . GC-specific ARKO mice display essentially the same phenotype as described for complete ARKO mice. Fertility is reduced with fewer litters per female, fewer pups per litter and premature ovarian failure. The length of the estrous cycles is increased, particularly in older animals, and there are fewer ovulated oocytes. In addition, the number of preantral and atretic follicles is increased and the number of antral follicles and corpora lutea is decreased. Finally, in vitro studies indicate that follicles, isolated from GC-specific ARKO mice grow at a significantly slower rate than follicles from WT animals, suggesting a role of the AR in normal preantral follicular growth.
Completely different results were observed after selective inactivation of the AR in oocytes using a Cre-recombinase driven by the promoter of growth differentiation factor 9 (Gdf-9) (Sen and Hammes, 2010) . Oocyte-specific ARKO mice display normal fertility, normal estrous cycles and normal ovarian morphology, although maturation of oocytes in in vitro cultures is no longer promoted by androgen treatment.
Taken together these data suggest that the observed reproductive phenotype in complete ARKO females is mainly due to a defect in androgen action at the level of the granulosa cells.
5. Cell-selective knockouts of the AR and the control of male sexual behavior A wide range of behaviors (sex, aggression, juvenile play. . .) and neuroendocrine functions (feedback effects of steroids on gonadotropin release, growth. . .) are sexually dimorphic. The mechanisms governing sexual differentiation of brain and behavior, however, are extremely complex and vary from species to species (Bonthuis et al., 2010) . There is plenty of evidence that gonadal steroid hormones play a key role in these processes and that their effects are both ''organizational'', leading to irreversible modifications in subsequent behavior, and ''activational'', inducing acute changes in the behavioral repertoire (Phoenix et al., 1959) . The available data support a central role for T in the masculinization of brain and behavior. Since T can be aromatized in the brain into E2, however, the relative contribution of AR and estrogen receptors (ERa and ERb) to the masculinization process remains unclear. Male mice null for aromatase or doubly mutant for ERa and ERb display profound defects in male-typical mating and territorial behavior, confirming a role for estrogens in the masculinization of the brain (Honda et al., 1998; Ogawa et al., 2000) . Male mice with global inactivation of AR (ARKO or Tfm), however, also lack male-typical sexual and aggressive behavior (Sato et al., 2004) . In the latter case, the interpretation of the observed defects is confounded by the peripheral effects of androgens and more particularly by the lack of external male genitalia. Selective knockouts of the sex hormone receptors in the nervous system may undoubtedly contribute to a better understanding of the role of AR and ER-signaling pathways in the masculinization of brain and behavior. Raskin et al. (2009) were the first to describe a mouse model with a selective inactivation of the AR in the nervous system (AR NesCre males). AR NesCre males were produced by crossing female mice homozygous for a floxed exon 2 (De Gendt et al., 2004) with male mice expressing the Cre recombinase selectively in neuronal and glial precursor cells under the control of the promoter and nervous system-specific enhancer of rat nestin (Nes) (Tronche et al., 1999) . AR NesCre mice display a normal male phenotype and a normal male urogenital tract. Testicular size is slightly reduced and serum T, E2 and LH levels are increased. Despite the disruption of AR in all relevant areas of the brain, the animals are able to produce offspring, albeit with variable and reduced levels of fertility. Sexual motivation and performance are clearly disrupted as reflected by increased latency to masculine behavior, prolonged length of copulation and reduced erectile activity. Importantly, a fraction of the mutant males fails to show any sexual behavior. AR NesCre mice also exhibit low and heterogenous aggressive behavior in resident intruder tests. Nonetheless, discrimination between male and female nonvolatile olfactory cues, chemo-investigative behavior and induction of neuronal activity following exposure to estrous female-soiled bedding (as mapped by Fos immunoreactivity) are normal. Treatment of gonadectomized AR NesCre mice with the non-aromatizable androgen DHT fails to reinstate sexual behavior suggesting that the remaining sexual behavior is due to the activation of ER signaling pathways. Taken together the data indicate that cerebral AR and ER signaling pathways play complementary roles in T-induced regulation of male typical behaviors. By an identical approach, Juntti et al. (2010) also developed a mouse model (AR NsDel ) with selective AR deletion in the nervous system. Surprisingly, these animals displayed neither the slight decrease in testis weight nor the endocrine defects observed in AR NesCre mice. The reason for this discordance is at present unclear.
Nonetheless, the observed defects in male sexual behavior were comparable (although not identical) to those observed in AR NesCre mice. AR NsDel males show a lowered probability of initiating mating behavior and a reduction in the number of mounts, intromissions and ejaculations. While they are less likely to mate, once sexual behavior is initiated, its display resembles that of WT males. This suggests that the AR controls the probability of mating rather that the pattern of this complex behavioral routine. As in AR NesCre mice, the defect seems not to be due to an inability to distinguish sexes or to reduced chemo-investigation. Moreover, AR NsDel males also display defects in male territorial behavior. In light of the observation that AR expression in relevant brain areas is very limited in the neonatal period but can be induced by estrogens, the authors suggest that, in the neonatal period, T may act as a precursor to estrogens to masculinize the brain via ER-mediated signaling pathways whereas during subsequent development androgen action via AR is needed to control the levels of male behavioral display (Hamson et al., 2010; Juntti et al., 2010) .
Male accessory sex glands

Prostate and seminal vesicles
In many androgen target tissues and more specifically in androgen-dependent glands such as the prostate, the seminal vesicles and the epididymis, AR is expressed and active both in the epithelial and stromal compartments. Stromal-epithelial interactions have been shown to be essential for glandular development and are also known to play a key role in diseases such as prostate hypertrophy and prostate cancer (Cunha et al., 2004) . Tissue recombination experiments have been used to study the role of stromal and epithelial androgen action in the communication between these two compartments (Cunha et al., 2004 ) but conditional knockout technology opens a novel avenue to address this problem in a more physiological setting.
Selective knockouts of AR in prostatic epithelial cells have been generated by crossing mouse strains expressing the Cre recombinase under the control of the probasin promoter with mice carrying an AR allele with a floxed exon 2 (pes-ARKO (Wu et al., 2007) ) or a floxed exon 3 (PEARKO (Simanainen et al., 2007) ). Different probasin-driven Cre strains were used to generate pes-ARKO and PEARKO mice. In pes-ARKO mice Cre expression is limited to the prostate and AR ablation is most pronounced in the ventral prostate (which increases in size) and is less obvious in the dorsolateral and anterior prostate. Ablation of AR is accompanied by increased mitogenesis in the otherwise growth-quiescent adult epithelium. Differentiation of the epithelium, however, is impaired as shown by decreased epithelial height and glandular infolding, decreased expression of epithelial markers, increased epithelial sloughing and increased luminal cell apoptosis. In PEARKO mice Cre is expressed not only in the prostatic epithelium but also in the epithelium of the epididymis and the ductus deferens and in the stromal smooth muscle cells of seminal vesicles. In this model prostate size is reduced in a lobe-specific way (mainly in the anterior and dorsolateral prostate) but branching morphogenesis remains normal indicating a cardinal role for the stromal AR in the development and maintenance of ductal architecture. Comparable to the findings in pes-ARKO mice, structural and functional differentiation of the prostatic epithelium is hindered and foci of increased proliferation and abnormal clustering of epithelial cells are observed supporting a role for the epithelial AR in the suppression of proliferation. Studies on gonadectomized and androgen treated PEARKO mice present additional support for the contention that epithelial AR ablation sensitizes prostate epithelial cells to paracrine signals produced in the stromal compartment under control of aromatizable androgens (Simanainen et al., 2009) .
In contrast with pes-ARKO mice, PEARKO mice display reduced fertility. This subfertility is apparently due to defective androgen action not only in the prostate, but also in the seminal vesicles and in the epididymis (Simanainen et al., 2008) . Specifically, copulatory plug formation is disrupted, epididymal transit kinetics are disturbed and sperm maturation is defective, resulting in an increased rate of spontaneous acrosome reaction and abnormal flagellar morphology. The fertilizing ability of PEARKO sperm in vitro appears to be normal, confirming that the observed subfertility is due to reduced accessibility of sperm to oocytes in the female reproductive tract. The differences between the pes-ARKO and PEARKO models can probably largely be ascribed to the use of different Cre mouse strains.
The role of androgen action in prostatic stroma has been addressed in a model targeting AR in stromal smooth muscle cells (SM-ARKO) (Yu et al., 2010) . The model uses the same transgelin-Cre strain as that used in an attempt to inactivate the AR in testicular PTMC. Cre expression and AR inactivation are mainly observed in smooth muscle cells of the anterior prostate. Inactivation is less effective or absent in the ventral and dorsolateral prostate, respectively. AR inactivation affects neither the gross appearance of the prostate nor the branching morphogenesis in the anterior prostate, however fewer infoldings into the lumen are noted in the glandular epithelium. Epithelial proliferation is decreased with few changes in apoptosis or differentiation. IGF-1 levels in stromal smooth muscle cells, as studied by immunohistochemistry, are markedly decreased and are suggested to be responsible at least in part for the reduced proliferation.
Similarly, the role for androgen action in the stroma of the seminal vesicles was explored in a model targeting AR in smooth muscle cells (PTM-ARKO) (Welsh et al., 2010a) . The model uses the Cre strain expressing Cre under the control of the myosin heavy chain promoter and was originally designed to inactivate the AR in PTMC. In seminal vesicles of adult PTM-ARKO mice the depth of the smooth muscle layer is decreased and epithelial cell proliferation is increased. The epithelial cells show functional impairment as reflected by reduced cell height and a general decrease in the production of seminal vesicle proteins. As in PEARKO mice copulatory plug formation is defective. Interestingly, treatment of PTM-ARKOs with E2 also indicates that AR-mediated smooth muscle-epithelial interactions limit the epithelial proliferative response to exogenous E2. In general the data point to a vital role of smooth muscle cells in androgen-driven stromal-epithelial interactions in seminal vesicles.
Studies of the specific role of epithelial and stromal AR have also been performed in a transgenic adenocarcinoma mouse model (TRAMP) in which AR was either selectively ablated in prostatic epithelium by use of a probasin-driven Cre (pes-ARKO-TRAMP mice), or ablated both in stroma and epithelium by use of an interferon-inducible Cre (ind-ARKO-TRAMP) (Niu et al., 2008a (Niu et al., ,b, 2010 . The data in pes-ARKO-TRAMP mice suggest that epithelial AR may function as a proliferation suppressor in epithelial basal-intermediate cells and a survival factor preventing apoptosis in luminal cells (findings resembling those made in pes-ARKO and PEARKO mice). The ind-ARKO-TRAMP model suggests that stromal AR may play a dominant role in the promotion of primary tumor proliferation particularly at an early stage of tumor development.
Proximal epididymis
Androgens are one of the most important regulators of epididymal development and function. However, the relative contribution of androgen signaling in stromal versus epithelial cells remains incompletely understood. Furthermore, the role of androgens may differ between different parts of the epididymis (Robaire et al., 2006) . In the proximal part of the organ, for instance, an important role may be played by (androgen-controlled) lumicrine factors produced by the testis. Recently two models have been developed to study the role of AR in the epithelial cells of the proximal epididymis. Both models used the AR flox mouse line developed in our laboratory (De Gendt et al., 2004) . In the first model (ProxE-ARKO) the AR flox mice were crossed with a novel mouse strain expressing the Cre recombinase under the control of the promoter of Rnase10, a gene with specific expression in the proximal epididymis (Krutskikh et al., 2010) . In the second model (caput epithelium AR knockout or CEARKO) the Cre mice carried a knock-in of the Cre recombinase at one copy of the FoxG1 locus (O'Hara et al., 2010). ProxE-ARKO mice display AR ablation in differentiating principal epithelial cells from postnatal d20 onward. Ablation begins abruptly in the margin between the efferent ducts and the initial segment (IS) and gradually wanes toward the distal end. In CEARKO mice AR ablation may start earlier but is seen in only a proportion of the principal epithelial cells (67% at d100). Both models display many similarities: the development of the IS is aborted, AR-negative epithelial cells show a decrease in height and cytoplasmic volume, no AR ablation is observed in the stroma, and intertubular space in the proximal epididymis is increased. Upon the start of spermiation, epididymal obstruction ensues with accumulation of proteinaceous exudate and cellular debris in the efferent ducts causing obstructive azoospermia and infertility. Fluid back pressure results in distention of efferent ducts and rete testis, degeneration of the seminiferous epithelium in the testis and, surprisingly, an increase in testis size in ProxE-ARKO and a decrease in testis weight in CEARKO mice. Taken together, the data indicate that stromal AR may play a major role in the initial stabilization of the Wolffian ducts in fetal life but that epithelial AR signaling is essential for postnatal development and function of the epididymal epithelium. Moreover, comparison of gene expression data in ProxE-ARKO mice as compared to mice with efferent duct ligation and orchidectomized animals clearly indicates that some genes in the proximal epididymis are controlled by circulating androgens, whereas others depend on lumicrine regulation via testicular efferent fluid and still others need both signaling pathways for normal expression (Krutskikh et al., 2010) .
7. Cell selective ablation of the AR: effects on muscle, fat, and bone metabolism and function Muscle, fat and bone are some of the largest tissues affected by androgens. Androgens are, at least in part, responsible for the marked sexual dimorphism observed in the development and function of these tissues in many species. Moreover, androgen deficiency or excess may result in major disturbances in muscle, fat and bone metabolism. Finally all these tissues are considered potential targets for androgen therapy under a variety of conditions.
Muscle
The mechanisms of androgen action in muscle remain poorly understood (MacLean and Handelsman, 2009 ). Skeletal muscles express AR, however, with the exception of some muscles specifically related to sexual function (e.g., the levator ani or LA), expression levels tend to be low. Moreover, in muscular tissue, AR expression is observed in a variety of cell types including mesenchymal stem cells, fibroblasts, satellite cells and myofibers. Furthermore, androgen action affects not only adult muscle mass and function, but also differentiation of pluripotent stem cells into myoblasts and myocytes. Finally, androgens affect muscle cells not only directly but also by a variety of indirect mechanisms for instance by acting as precursors for other steroid hormones (e.g., estrogens) or by affecting food intake, GH/IGF-1 secretion or androgen-responsive motoneurons (MacLean et al., 2008b; MacLean and Handelsman, 2009; Ophoff et al., 2009) . The production of cellselective AR knockouts is a logical step in the study of androgen signaling in this important target tissue.
Thus far, two myocyte-selective AR-ablation models have been generated. The first model ) is a post-mitotic myocyte-specific AR knockout (mARKO) produced by crossing female mice homozygous for the AR flox allele (De Gendt et al., 2004) with male mice expressing the Cre recombinase under the control of the muscle creatine kinase promoter (MCK-Cre). The MCK-Cre is selectively expressed in mature, post-proliferative myofibers (from embryonic d13 on) but not in satellite cells or myoblasts. mARKO mice display a 60-88% decrease in muscle AR protein expression, as assessed by western blotting, and a significant decrease (À8%) in lean body mass. A significant decrease in muscle weight, is only observed for the LA (À46%) and the extensor digitorum longus (À14%) but not for the other hind limb muscles investigated. In some muscles (M soleus) AR ablation is accompanied by a conversion of fast fibers toward slow fibers (an observation also made in mice with a global AR knockout). Surprisingly, however, these changes do not affect muscle strength or fatigue.
No effects are observed on skeletal homeostasis but intra-abdominal fat is significantly decreased suggesting an effect of myocyte AR action on fat homeostasis . In the second model (AR skmÀ/y ) (Chambon et al., 2010) mice with a floxed exon 1 were crossed with mice expressing the Cre recombinase under the control of the a-skeletal actin promoter (expressed from d10 post-coïtum). Also in this model, myocytespecific AR ablation results in a significant decrease in LA weight but does not affect the mass of the studied limb muscles. The decrease in weight in the LA is accompanied by a decrease in androgen-induced IGF-1Ea. This decrease is not observed in the other muscles. Castration reduces leg muscle mass to a similar extent in AR skmÀ/y mice than in control mice, suggesting that the effects of androgens on muscle mass may be mediated by a signaling pathway independently from myocytic AR. In sharp contrast with the mARKO model, decreased muscle strength is observed in the limb muscles of AR skmÀ/y mice.
It is, at present, unclear whether the discrepancies between the described models are due to technical factors (different floxed AR alleles, different Cre mice. . .), differences in genetic background, differences in evaluation of muscle strength or other factors. Further research in this area is absolutely required. The models, however, clearly show that responses seen in the highly androgen dependent LA are not representative for effects occurring in classical skeletal muscles. Further study is required to determine whether the discrepancies observed between LA and other muscles reflect only a quantitative difference in androgen responsiveness or -as suggested by the AR skmÀ/y model-whether they imply qualitatively different mechanisms of regulation. The available data, however, suggest that the use of the LA may not be appropriate to identify selective AR modulators that are able to stimulate muscle strength in peripheral skeletal muscles.
Fat tissue and lipid accumulation
There is considerable evidence, for instance from studies in the aging male, that testosterone deficiency may contribute to the accumulation of visceral fat tissue, insulin resistance and the metabolic syndrome (Zitzmann, 2009) . In some mouse models with global ablation of AR, an age-dependent development of obesity has been observed from week 10 on (Lin et al., 2005; Sato et al., 2003) . This may not be a universal characteristic of AR deficient animals, however, since, for reasons that are presently unclear, such a decrease was never observed in our ARKO model (Verhoeven et al., 2007) . The pathogenesis of this type of obesity also remains only partially understood. In one of the strains of ARKO mice with obesity (AR(LÀ/Y)) the affected animals are euphagic but less dynamic than control mice (Fan et al., 2005) . Secretion of the insulin-sensitizing adiponectin is enhanced but expression of peroxisome proliferator activated receptor gamma in white adipose tissue is decreased. Overall insulin sensitivity is unaffected despite the obesity. In the other strain of ARKO mice with obesity (AR À/y ), the accelerated weight gain is accompanied by progressive insulin resistance, hyperinsulinemia, hyperglycemia and hyperleptinemia (Lin et al., 2005) . Administration of leptin fails to stimulate weight loss suggesting leptin resistance. Adipocytes derived from embryonic fibroblasts from (AR À/y ) mice secrete considerably more leptin than those derived from normal (AR +/y ) controls, suggesting that AR signaling may contribute to leptin production and secretion by adipocytes. A model with selective ablation of AR in adipose tissue (A-AR À/y ) has been generated by the use of a mouse strain expressing the Cre recombinase under the control of the aP2 (Fatty Acid Binding Protein 4, FABP4) promoter . Interestingly, A-AR À/y mice display the same body weight and adiposity as male WT controls. Exactly as complete AR À/y mice, A-AR À/y mice show hyperleptinemia but there seems to be no leptin resistance. In addition, triglyceride and cholesterol levels are decreased suggesting a beneficial effect of the high leptin levels independent of fat deposition.
It is obvious that considerably more work will be needed to clarify the signaling pathways by which androgens affect fat tissue and metabolism. Together the available evidence indicates that these pathways are complex and at least in part indirect. Leptin and adiponectin production in adipocytes may be some of the targets involved.
It should be mentioned that androgens may also affect lipid accumulation in other organs/tissues than fat tissue. Hepatic steatosis and insulin resistance have been reported, for instance, in a mouse model with selective ablation of AR in the liver (using a Cre driven by the albumin promoter) . The increased steatosis correlates with decreased fatty acid oxidation and increased de novo lipogenesis. Increased insulin resistance is associated with increased expression of protein tyrosine phosphastase 1B, a negative regulator of insulin action.
Bone
Sex hormones and disturbances in sex hormone production and action have marked effects on bone development and skeletal homeostasis (Callewaert et al., 2010a,b) . Once more, however, the signaling pathways involved are complex. Estrogens and androgens play a role in both sexes but their relative contribution is obviously gender-dependent. Recent studies in mice with a global KO of AR support a role for androgens in skeletal homeostasis in male and female mice (Callewaert et al., 2010b; MacLean et al., 2010) . The effects of AR ablation have been studied most extensively in ARKO males . In these mice skeletal androgen action is mediated both directly through activation of AR and indirectly through activation of ERa after aromatization of circulating androgens (Callewaert et al., 2010a) . Direct AR signaling is apparently the main factor preventing trabecular bone loss, while both AR and ER signaling are needed for the maintenance of cortical bone ). The situation is further complicated by the finding that at least part of the effects of estrogens is mediated by changes in IGF-1 and that both AR and ER signaling affect the response of bone to loading (Callewaert et al., 2010b) . The relative contribution of different target cells (osteoblasts, osteoclasts, osteocytes, chondrocytes. . .) to androgen (and estrogen) signaling in bone remains largely unknown.
At present, two models have been developed targeting AR in osteoblasts. Both models use a mouse strain carrying an AR allele with a floxed exon 3. In the first model (Col2.3-ARKO) AR was specifically deleted in mature osteoblasts using a mouse strain expressing the Cre recombinase under the control of a 2.3 kb fragment of the rat type 1a1 collagen promoter (Col2.3-Cre) (Notini et al., 2007) . The model shows that AR in mature osteoblasts is needed to maintain trabecular bone volume by regulating bone resorption. No effects are observed on bone size. In the second model (mOBL-ARKO) AR is deleted specifically in terminally differentiated mineralizing osteoblasts using a mouse line expressing Cre under the control of the human osteocalcin promoter (Chiang et al., 2009) . mOBL-ARKO mice show that AR in mineralizing osteoblasts is needed to maintain trabecular and cortical bone architecture by regulating both bone resorption and the coupling of bone matrix synthesis and mineralization. This action is apparently most important during pubertal growth when rapid bone remodeling is required. The described models nicely demonstrate how AR deletion at different stages of development may result in phenotypes that are only partially overlapping. The interpretation of the results in such models is further complicated by the fact that the efficiency of AR ablation may differ depending on the Cre line used and that the degree of AR deletion is difficult to determine in a complex tissue such as bone.
Other tissues and processes
Sexual dimorphism is observed in a number of processes and diseases related to host defense mechanisms and the immunological system. In some of these processes androgens and AR may be involved. Cutaneous wound healing, for instance, occurs more slowly in elderly males than in elderly females and some data point to a role of androgens in this process (Ashcroft and Mills, 2002) . In healing skin AR is expressed in infiltrating macrophages, keratinocytes and fibroblasts. To define the relative contribution of these potential target cells to the delayed wound healing in males, Lai et al. (2009) recently generated mice with a myeloid-specific (MARKO), a keratinocyte-specific (KARKO) or a fibroblast-specific (FARKO) AR knockout. To this end mice with an AR allele containing a floxed exon 2 were crossed with mice carrying a targeted insertion of Cre cDNA into the M lysozyme locus (Lyz-Cre), mice expressing Cre under the control of the keratin 5 promoter (K5-Cre) or mice expressing Cre under the control of fibroblast specific protein-1 promoter (Fsp-Cre) respectively. Using these model systems the authors demonstrate that global ARKO mice and MARKO mice exhibit accelerated wound healing as compared to WT males, whereas KARKO and FARKO do not. Furthermore they present evidence that this effect is mainly related to AR action in monocytes/ macrophages resulting in enhanced local TNFa expression. Intriguingly, in this model the effects of AR seem to be mediated both by androgen-dependent and androgen-independent signaling pathways.
Conclusions
Cell-selective knockout technology has become a very powerful tool in the analysis of the cellular and molecular pathways mediating androgen action in vivo. In a number of androgen-controlled processes this technology has pointed to one particular cell type as the key mediator of androgen action. Notorious examples are the identification of the SC as the main target by which androgens control spermatogenesis and male fertility (Fig. 1) and the identification of the granulosa cell as the cardinal mediator of the effects of androgens on follicular development and female fertility. The main message of the experiments summarized above, however, is that in most organs and tissues the phenotypic effects of androgens are the result of a complex interplay between distinct and specific androgen target cells. Some of the most prominent examples of this interplay are the mesenchymal-epithelial interactions observed in most male accessory sex tissues and also in the testis. In a typical target organ such as the prostate epithelial AR contributes to epithelial differentiation and suppression of epithelial proliferation while AR in stromal myoid cells contributes to epithelial growth and branching morphogenesis (Fig. 2) . Responses (and efficiency of AR knockout) may differ in different prostate lobes, however, and in seminal vesicles inactivation of the stromal myoid AR stimulates rather than inhibits epithelial proliferation. More research is obviously needed to study the effects of AR inactivation in non-myoid stromal cells and to study the effects of stromal and epithelial AR inactivation at different points during development. Apart from mesenchymal-epithelial interactions other target cell interactions mediated by paracrine or endocrine mediators may play a role in the effects of androgens on tissues such as muscle, bone and adipose tissue. A further area where cell-selective AR knockouts contribute to our understanding of androgen action is that of the role of active metabolites. Studies on the role of AR in the nervous system are compatible with the hypothesis that perinatal masculinization of the brain is mainly mediated via ER whereas postnatal activation of AR is responsible for the potentiation of specific aspects of male behavior. Similarly, general and selective receptor knockout studies in bone point to distinct contributions of AR-and ER-mediated signaling pathways to trabecular and cortical bone formation. Finally, cell-selective knockouts have proven to be a valuable tool in the search for androgen-regulated genes in cell types such as SC and epithelial cells from the epididymis. Further research in this area will undoubtedly contribute to the dissection of the molecular pathways mediating androgen action. It may reasonably be expected that a better understanding of all these complexities of androgen signaling may open novel avenues for more selective modulation of androgen action.
The answers provided by conditional knockout technology are not always unequivocal and users and readers should be aware of the technical limitations and the potential artifacts. Part of the ambiguity of the observed responses may simply be due to the fact that the underlying mechanisms are more complex than previously suspected. For example, as discussed above, the effects of androgens on muscle not only reflect effects on differentiated myocytes but also on precursor cell differentiation, effects on production of paracrine and endocrine mediators, effects on responsiveness to muscle loading, effects on general level of activity and other factors. Apart from these inherent complexities, however, it should be noted that Cre mouse strains are only rarely as selective as claimed and that Cre expression patterns may differ at various stages of development. Such 'ectopic' expression may confound correct interpretation of the data and, thus, further study is required. Furthermore, even if Cre is expressed selectively in the targeted cell type, expression is obviously not always sufficient to guarantee AR ablation in 100% of the target cells. Incomplete inactivation is often difficult to document in tissues containing different types of AR expressing cells, particularly if the level of expression is low. Additionally, it should be noted that both floxed mice and Cre mice are transgenic animals and that the genetic manipulations underlying their creation may result in unexpected effects. This implies that in conditional knockout experiments the phenotype of the knockout animals needs to be compared not only to that of WT controls but also to that of controls carrying only the floxed allele and controls expressing only Cre recombinase. If these distinct controls display different phenotypes, interpretation of the data may become impossible. Finally, it should be mentioned that further improvement and sophistication of conditional knockout technology is certainly needed. It would be extremely valuable to be able to control the expression of the Cre recombinase in a spatiotemporal manner. Inducible Cre systems are available but they are often leaky or require administration of exogenous compounds provoking undesired off-target effects (such as the Tamoxifeninducible Cre model (Metzger and Chambon, 2001) ). Further research in this area may considerably expand the experimental power of cell-selective knockout technology.
